hemophilia A – Medneed

Biologic Newly Approved

ROCTAVIAN a virus vector-based gene therapy for hemophilia A

Tradename: ROCTAVIAN Proper Name: valoctocogene roxaparvovec-rvox Indication: Valoctocogene roxaparvovec-rvox is an adeno-associated virus vector-based gene therapy indicated for the treatment of adults with severe hemophilia A (congenital factor VIII deficiency…

Biologic Hemophilia A Newly Approved

ALTUVIIIO for use in Hemophilia A patients

Tradename: ALTUVIIIO Proper Name: antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl Indication: Indicated for use in adults and children with Hemophilia A (congenital Factor VIII deficiency) for: (1) Routine prophylaxis to…